Established by the International Myeloma Foundation (IMF) at a meeting in Singapore in 2011, the Asian Myeloma Network® (AMN) is the first of its kind in the region and is comprised of myeloma experts from China, Hong Kong, Malaysia, Taiwan, Japan, Philippines, Singapore, South Korea, Vietnam, and Thailand. The AMN has taken the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Since its founding, the AMN has: created a unified database to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies; launched and overseen clinical trials; enabled myeloma patients to gain access to the newest myeloma treatments; developed informational resource materials in local languages, especially for patients and caregivers; and engaged in collaborative studies.
Asian Myeloma Network (AMN) History
On March 17, 2011, the International Myeloma Foundation (IMF) established the Asian Myeloma Network (AMN) at a meeting in Singapore. Comprised of myeloma experts from China, Hong Kong, Malaysia,Taiwan, Japan, South Korea, Singapore, and Thailand, the IMF Asian Myeloma Network — the first of its kind in the region — has taken the lead in projects to assist IMF in providing physician education and patient support throughout Asia. Myeloma is a growing health problem in Asia, with an incidence that is approaching that in Western countries, but with a much larger population base.
Since its founding, the AMN has:
- Created a unified database to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies.
- Launched and overseen clinical trials.
- Enabled myeloma patients to gain access to the newest myeloma treatments.
- Developed informational resource materials in local languages, especially for patients and caregivers.
- Engaged in collaborative studies.
Executive Committee
Wee Joo Chng, MD — Chairperson of the AMN Executive Committee
Dr. Wee Joo Chng has been a Senior Consultant at the National University Cancer Institute, Singapore, part of the National University Health System, for almost two decades. He is an esteemed researcher in genomics, therapeutics and hematologic malignancies, with extensive experience in clinical practice, administration, and leadership. Dr. Chng is currently the Yong Loo Lin Professor in Medical Oncology, Vice President (Biomedical Sciences Research), and Senior Principal Investigator of the Cancer Science Institute of Singapore, at the National University of Singapore.
- Masahiro Abe
- Priscilla B. Caguioa
- Wenming Chen
- James Chim
- Gin Gin Gan
- Hiroshi Handa
- Jeffrey Huang
- Shinsuke Iida
- Hou Jian
- Jin Soek Kim
- Kihyun Kim
- Pankaj Malhotra
- Chandramouli Nagarajan
- Teeraya Puavilai
- Sen Mui Tan
- Rosalio P. Torres
- Uday Yanamandra
Executive Staff
- Daniel Navid
- Lisa Paik
| Name | Country | Institution |
|---|---|---|
| Guangzhong Yang Beijing Chao-Yang Hospital, Capital Medical University China | China | Beijing Chao-Yang Hospital, Capital Medical University |
| Wei Yang Shengjing Hospital of China Medical University China | China | Shengjing Hospital of China Medical University |
| Hiroshi Yasui St. Marianna University School of Medicine Japan | Japan | St. Marianna University School of Medicine |
| Ho-Young Yhim Chonbuk National University, Jeonju, South Korea South Korea | South Korea | Chonbuk National University, Jeonju, South Korea |
| Jun Ho Yi Chung-ang University Hospital South Korea | South Korea | Chung-ang University Hospital |
| Sang Eun Yoon Sungkyunkwan University School of Medicine Samsung Medical Center South Korea | South Korea | Sungkyunkwan University School of Medicine Samsung Medical Center |
| Dok Hyun Yoon University of Ulsan College of Medicine Asan Medical Center South Korea | South Korea | University of Ulsan College of Medicine Asan Medical Center |
| Sung-Soo Yoon Seoul National University Hospital [Chairman (Korean Multiple Myeloma Working Party); Professor/Director (Division of Hematology/Medical Oncology] South Korea | South Korea | Seoul National University Hospital [Chairman (Korean Multiple Myeloma Working Party); Professor/Director (Division of Hematology/Medical Oncology] |
| Satoshi Yoshihara Hyogo Medical University Japan | Japan | Hyogo Medical University |
| Melinda Tan Si Yun Singapore General Hospital Singapore | Singapore | Singapore General Hospital |
| Li Zhang
West China Hospital Sichuan University China |
China | West China Hospital Sichuan University |
| Jing Zheng Department of Hematology，Fujian Medical University Union Hospital, Fujian Institution of Hematology China | China | Department of Hematology，Fujian Medical University Union Hospital, Fujian Institution of Hematology |
| Yuping Zhong Qingdao Municipal Hospital，School of Medicine，Qingdao University China | China | Qingdao Municipal Hospital，School of Medicine，Qingdao University |
| Lu Zhong Ren Ji Hospital China | China | Ren Ji Hospital |
| Junling Zhuang Peking Union Medical College Hospital China | China | Peking Union Medical College Hospital |
